Citi Downgrades Puma Biotechnology (PBYI) to Neutral
Tweet
Share
E-mail
Get Alerts PBYI Hot Sheet
Price: $7.99 +0.13%
Rating Summary:
5 Buy, 6 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 66
Rating Summary:
5 Buy, 6 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 66
Join SI Premium – FREE
Citi analyst Yigal Nochomovitz downgraded Puma Biotechnology (NASDAQ: PBYI) from Buy to Neutral with a price target of $24.00.
For an analyst ratings summary and ratings history on Puma Biotechnology click here. For more ratings news on Puma Biotechnology click here.
Shares of Puma Biotechnology closed at $19.50 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- B.Riley Downgrades Capricor Therapeutics (CAPR) to Neutral
- Goldman Sachs Downgrades Vale S.A. (VALE) to Neutral
- Brean Capital Downgrades FS Bancorp (FSBW) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
